Clinical Trial Update: Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of grazoprevir/elbasvir in early chronic hepatitis C among HIV/HCV co-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Zepatier (elbasvir/grazoprevir)

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Hepatitis C, HIV | Phase 3 | Status: UNKNOWN